» Articles » PMID: 12933667

Transactivation of Steroidogenic Acute Regulatory Protein in Human Endometriotic Stromalcells is Mediated by the Prostaglandin EP2 Receptor

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2003 Aug 23
PMID 12933667
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Steroidogenic acute regulatory protein (StAR) regulates the first committed step in the biosynthesis of steroids, and thus aberrant expression of StAR in endometriotic implants plays a critical role in the etiology of endometriosis. However, the mechanism responsible for abnormal expression of StAR in ectopic endometriotic tissues remains unknown. In the present study, we demonstrate that prostaglandin (PG) E(2) stimulates StAR protein expression at the cellular and molecular levels. PGE(2) caused a rapid increase in StAR expression that involves activation of the EP2 receptor-coupled protein kinase A pathway. Activation of EP2 receptor-induced phosphorylation of ERK and cAMP response element binding protein (CREB). However, activation of ERK did not involve in CREB phosphorylation or concomitantly StAR expression. Phosphorylation of CREB induced by PGE(2) increased the recruitment of CREB binding protein and thus histone H3 acetylation. Chromatin immunoprecipitation experiments showed that acetylated histone H3 bound to the proximal region of the StAR promoter was increased after 30 min treatment with PGE(2), and this was mirrored by an increase in nascent StAR RNA transcription. Treatment with the histone deacetylase inhibitor, tricostatin A, enhanced PGE(2)-induced nascent StAR RNA transcription. We conclude that increased histone H3 acetylation involving the EP2 receptor, protein kinase A, CREB, and CREB binding protein is responsible for PGE(2)-induced StAR gene activation in endometriotic stromal cells. Our current report may provide new insights in understanding mechanism of abnormally local production of estrogen and the etiology of endometriosis.

Citing Articles

Exercise and endometriosis-is there a promising future? A narrative review.

McKnight K, Omotosho O, Jassim S, Cotter A Ir J Med Sci. 2024; 193(5):2375-2387.

PMID: 38916808 DOI: 10.1007/s11845-024-03733-2.


The "Road" to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review.

Hablase R, Kyrou I, Randeva H, Karteris E, Chatterjee J Cancers (Basel). 2024; 16(11).

PMID: 38893278 PMC: 11172073. DOI: 10.3390/cancers16112160.


The involvement of RNA N6-methyladenosine and histone methylation modification in decidualization and endometriosis-associated infertility.

Lin X, Dai Y, Gu W, Zhang Y, Zhuo F, Zhao F Clin Transl Med. 2024; 14(2):e1564.

PMID: 38344897 PMC: 10859880. DOI: 10.1002/ctm2.1564.


An Investigation of Steroid Biosynthesis Pathway Genes in Women with Polycystic Ovary Syndrome.

Sharma P, Jain M, Halder A J Hum Reprod Sci. 2022; 15(3):240-249.

PMID: 36341008 PMC: 9635380. DOI: 10.4103/jhrs.jhrs_86_22.


Metformin as a Potential Treatment Option for Endometriosis.

Kimber-Trojnar Z, Dluski D, Wierzchowska-Opoka M, Ruszala M, Leszczynska-Gorzelak B Cancers (Basel). 2022; 14(3).

PMID: 35158846 PMC: 8833654. DOI: 10.3390/cancers14030577.